SELLAS Life Sciences Group, Inc. SLS Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$29.46M-9.7% | -$26.86M-3.6% | -$25.94M+1.2% | -$26.26M+3.2% | -$27.13M+12.2% | ||
| $2.25M+15.0% | $1.96M+3.9% | $1.88M+6.9% | $1.76M+10.5% | $1.59M+1.9% | ||
| -$28.17M+0.8% | -$28.39M+7.3% | -$30.62M+2.4% | -$31.36M+7.0% | -$33.71M+4.8% | ||
| $106.87M+23.8% | $86.3M+60.1% | $53.91M+13.5% | $47.51M+8.7% | $43.69M-6.6% | ||
| $81.8M+34.1% | $61.01M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does SELLAS Life Sciences Group, Inc. generate?
- SELLAS Life Sciences Group, Inc. (SLS) generated -$28.2M in operating cash flow over the trailing twelve months.
- Where does SELLAS Life Sciences Group, Inc.'s cash flow data come from?
- Every line is extracted from SELLAS Life Sciences Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.